Organogenesis Hldgs Q4 2023 GAAP EPS $0.010, Inline, Sales $99.651M Miss $109.050M Estimate
Organogenesis Hldgs Q4 2023 GAAP EPS $0.010, Inline, Sales $99.651M Miss $109.050M Estimate
Organogenesis Hldgs 2023年第四季度GAAP每股收益爲0.010美元，內聯，銷售額爲996.51億美元，低於預期的1.0905億美元
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.010 per share which met the analyst consensus estimate. The company reported quarterly sales of $99.651 million which missed the analyst consensus estimate of $109.050 million by 8.62 percent. This is a 13.73 percent decrease over sales of $115.516 million the same period last year.
Organogenesis Hldgs（納斯達克股票代碼：ORGO）公佈的季度收益爲每股0.010美元，符合分析師的共識預期。該公司公佈的季度銷售額爲996.51億美元，比分析師普遍預期的1.0905億美元低8.62％。這比去年同期的1.15516億美元的銷售額下降了13.73％。